Patents by Inventor Kristian Jensen

Kristian Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME
    Publication number: 20130017996
    Abstract: The present invention relates to novel muteins derived from human tear lipocalin. The invention also refers to a corresponding nucleic acid molecule encoding such a mutein and to a method for its generation. The invention further refers to a method for producing such a mutein. Finally, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various uses of the mutein.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 17, 2013
    Inventors: Kristian Jensen, Martin Huelsmeyer, Steffen Schlehuber, Andreas Hohlbaum, Arne Skerra, Eric Boudreau, Richard Jones, Ian Kimber, Rebecca Dearman
  • Muteins of tear lipocalin and methods for obtaining the same
    Patent number: 8313924
    Abstract: The present invention relates to novel muteins derived from human tear lipocalin. The invention also refers to a corresponding nucleic acid molecule encoding such a mutein and to a method for its generation. The invention further refers to a method for producing such a mutein. Finally, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various uses of the mutein.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: November 20, 2012
    Assignee: Pieris AG
    Inventors: Kristian Jensen, Martin Huelsmeyer, Steffen Schlehuber, Andreas Hohlbaum, Arne Skerra, Eric Boudreau, Richard Jones, Ian Kimber, Rebecca Dearman
  • Method of treating a surface, coating compositions and use thereof and coated surfaces obtainable by the use
    Patent number: 7638165
    Abstract: A method of treating a surface comprising the steps of providing a coating composition comprising particles of a polyolefin wax or of a mixture of polyolefin waxes suspended in a liquid phase; applying said coating composition to the surface; evaporating said liquid phase from the applied coating composition; and subjecting said dried, applied coating composition to a heating treatment to coalesce said wax particles.
    Type: Grant
    Filed: July 16, 2003
    Date of Patent: December 29, 2009
    Assignee: Biopoint APS
    Inventor: Knud Erik Kristian Jensen Moller
  • MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME
    Publication number: 20090305982
    Abstract: The present invention relates to novel muteins derived from human tear lipocalin. The invention also refers to a corresponding nucleic acid molecule encoding such a mutein and to a method for its generation. The invention further refers to a method for producing such a mutein. Finally, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various uses of the mutein.
    Type: Application
    Filed: August 1, 2007
    Publication date: December 10, 2009
    Inventors: Kristian Jensen, Martin Huelsmeyer, Steffen Schlehuber, Andreas Hohlbaum, Arne Skerra, Eric Boudreau, Richard Jones, Ian Kimber, Rebecca Dearman
  • Neuropilin-1 inhibitors
    Publication number: 20060115477
    Abstract: The present invention relates to molecules interfering with the function of neuropilin-1 in the context of angiogenesis and the treatment of cancer. Molecules, polypeptides, antibodies, compositions and methods are provided that are useful for reducing, inhibiting or treating angiogenesis, the invasion of blood vessels into tumors, and/or the invasion or the metastatic potential of specific tumor cells. Additionally, a method is provided that allows identifying molecules, which interfere with the functionality of neuropilin-1. Furthermore, a method is provided that allows determining whether a naturally occuring tumor cell depends on functional neuropilin-1 for its invasiveness and/or metastatic potential.
    Type: Application
    Filed: December 22, 2003
    Publication date: June 1, 2006
    Inventors: Christine Unger, Gerald Beste, Carolin Zehetmeier, Blanca Lain, Claudia Torella, Jens Niewohner, Daniel Jay, Brenda Eustace, Roland Knauer, Kristian Jensen